Andrea Axtell, MD, MPH
- Division of Cardiothoracic Surgery
Andrea L. Axtell, MD, MPH is an Assistant Professor in the Department of Surgery and Division of Cardiothoracic Surgery at the University of Wisconsin School of Medicine and Public Health. She is also the Surgical Director of the UW Carbone Cancer Center’s Thoracic Oncology Disease Oriented Team and a member of the Lung Cancer Screening Program at the William S. Middleton Veterans Hospital.
- MD, University of California San Francisco, San Francisco, CA, 2014
- MPH, Harvard University, Boston, MA, 2019
- Residency, General Surgery, Massachusetts General Hospital, Boston, MA, 2021
- Research Fellowship, Cardiac Surgery and General Surgery, Massachusetts General Hospital, Boston, MA, 2019
- Fellowship, Cardiothoracic Surgery, Massachusetts General Hospital, Boston, MA, 2023
Dr. Axtell’s primary clinical practice includes the treatment of patients with thoracic malignancies, including chest wall tumors, lung and esophageal cancer, and tracheal and mediastinal malignancies. She is particularly interested in the development of minimally invasive techniques for cancer surgery and has an expertise in both thoracoscopic and robotic surgery.
Dr. Axtell provides a wide range of services including Bronchoscopy, Thoracoscopic Lobectomy, Segmentectomy, Extrapleural Pneumonectomy, Thoracoscopic Thymectomy, Chest Wall Tumor Resection, Chest Wall and Thoracic Reconstruction, Tracheal Resection, Thoracoscopic Talc Pleurodesis, Pleurectomy and Decortication, Esophagectomy (Minimally-invasive), Laparoscopic and Robotic Paraesophageal Hernia Repair.
Dr. Axtell’s research interests include health services and clinical outcomes research. She has a particular interest in the biology, screening, and management of patients with lung cancer and an expertise in predictive analytics, risk-development modeling, and outcomes research focused on improving the care of her patients.
Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35.
Wasfy JH, Achanta A, Hidrue MK, Urbut S, Axtell AL, Berman AN, Zhao Y, Chen J, Gustus S, Picard MH
Open Heart 2023 Aug; 10(2)
[PubMed ID: 37625819]
Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection.
Axtell AL, David EA, Block MI, Parsons N, Habib R, Muniappan A
Ann Thorac Surg 2023 Sep; 116(3): 533-541
[PubMed ID: 37271447]
Contributing factors to lymph node recovery with esophagectomy by thoracic surgeons: an analysis of the Society of Thoracic Surgeons General Thoracic Surgery Database.
Sachdeva UM, Axtell AL, Kroese TE, Chang DC, Mathisen DJ, Morse CR
Dis Esophagus 2022 Sep 14; 35(9)
[PubMed ID: 35091737]
Pre-COVID-19 National Mortality Trends in Open and Video-Assisted Lobectomy for Non-Small Cell Lung Cancer.
Dezube AR, Hirji S, Shah R, Axtell A, Rodriguez M, Swanson SJ, Jaklitsch MT, Mody GN
J Surg Res 2022 Jun; 274: 213-223
[PubMed ID: 35190329]
Management and outcomes of esophageal perforation.
Axtell AL, Gaissert HA, Morse CR, Premkumar A, Schumacher L, Muniappan A, Ott H, Allan JS, Lanuti M, Mathisen DJ, Wright CD
Dis Esophagus 2022 Jan 07; 35(1)
[PubMed ID: 34212186]